GUFIC BIOSCIENCES
Back to All Ratios
|
GUFIC BIOSCIENCES Last 5 Year EV/CE History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| EV/CE(x) | 4.01 | 3.70 |
What is the latest EV/CE ratio of GUFIC BIOSCIENCES ?
| Year | EV/CE |
|---|---|
| Mar2025 | 4.01 |
| Mar2024 | 3.70 |
How is EV/CE of GUFIC BIOSCIENCES Trending?
| Years | EV/CE | % Change | |
|---|---|---|---|
| Mar2025 | 4.01 | 8.38 | |
| Mar2024 | 3.7 | - | |
Other Financial Ratios of GUFIC BIOSCIENCES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of GUFIC BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUFIC BIOSCIENCES | ₹3,268.8 Cr | -2.7% | -11% | -30.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,477.0 Cr | 2.5% | 4% | -3.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,934.0 Cr | -1% | 0.5% | 9.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,469.0 Cr | 6.9% | 8.7% | 21% | Stock Analytics | |
| CIPLA | ₹123,250.0 Cr | 1.4% | -2.4% | -3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,038.0 Cr | 2.4% | -2.2% | -4.5% | Stock Analytics | |
GUFIC BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUFIC BIOSCIENCES | -2.7% |
-11% |
-30.2% |
| SENSEX | 1.4% |
2.4% |
5.1% |
You may also like the below Video Courses